» Articles » PMID: 20535717

Physicians' Knowledge and Attitudes Regarding Implantable Cardioverter-defibrillators

Overview
Journal Cardiol J
Date 2010 Jun 11
PMID 20535717
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Information is limited regarding the knowledge and attitudes of physicians typically involved in the referral of patients for implantable cardioverter-defibrillator (ICD) implantation.

Methods: We conducted a survey of primary care physicians and cardiologists at the University of Rochester Medical Center and the Unity Health System Rochester, NY from December 2008 to February 2009. The survey collected information regarding physicians' knowledge of and attitudes towards ICD therapy.

Results: Of the 332 surveys distributed, 110 (33%) were returned. Over-all 94 (87%) physicians reported referring patients for ICD implantation. Eighteen (17%) physicians reported unawareness of guidelines for ICD use. Sixty-four (59%) physicians recommended ICD in patients with ischemic cardiomyopathy and left ventricular ejection fraction (LVEF) < or = 35%. Sixty-five (62%) physicians use < or = 35% as the LVEF criterion for ICD referral in patients with non-ischemic cardiomyopathy. Cardiologists were more familiar than primary care physicians with LVEF criteria for implantation of ICD in patients with ischemic and non-ischemic cardiomyopathy (p value 0.005 and 0.002, respectively). Twenty-nine (27%) participants were unsure regarding the benefits of ICDs in eligible women and blacks. Eighty two (76%) physicians believed that an ICD could benefit patients > or = 70 years old, whereas only 53 (49%) indicated that an ICD would benefit patients > or = 80.

Conclusions: A lack of familiarity with current clinical guidelines regarding ICD implantation exists. Primary care physicians are less aware of clinical guidelines than are cardiologists. This finding highlights the need to improve the dissemination of guidelines to primary care physicians in an effort to improve ICD utilization.

Citing Articles

Prevalence of One-Year Mortality after Implantable Cardioverter Defibrillator Placement: An Opportunity for Palliative Care?.

Kalver E, Branch-Elliman W, Stolzmann K, Wachterman M, Shin M, Schweizer M J Palliat Med. 2022; 26(2):175-181.

PMID: 36067080 PMC: 9894597. DOI: 10.1089/jpm.2022.0205.


Decision-making regarding primary prevention implantable cardioverter-defibrillators among older adults.

Hess P, Matlock D, Al-Khatib S Clin Cardiol. 2019; 43(2):187-195.

PMID: 31867773 PMC: 7021655. DOI: 10.1002/clc.23315.


Physicians' knowledge and attitudes in Saudi Arabia regarding implantable cardiac defibrillators.

AlHogbani T, Awwad F, Aljasser A J Saudi Heart Assoc. 2018; 30(2):108-112.

PMID: 29910581 PMC: 6000901. DOI: 10.1016/j.jsha.2017.05.002.


A roadmap for evaluating the use and value of durable ventricular assist device therapy.

Ward S, Liang Q, Pagani F, Zhang M, Kormos R, Aaronson K J Heart Lung Transplant. 2017; 37(1):146-150.

PMID: 28711453 PMC: 6746232. DOI: 10.1016/j.healun.2017.06.008.


Underutilization of Implantable Cardioverter Defibrillator in Primary Prevention of Sudden Cardiac Arrest.

Lakshmanadoss U, Sherazi S, Aggarwal A, Hsi D, Aktas M, Daubert J Cardiol Res. 2017; 2(1):1-6.

PMID: 28348654 PMC: 5358123. DOI: 10.4021/cr13w.


References
1.
Zipes D, Wellens H . Sudden cardiac death. Circulation. 1998; 98(21):2334-51. DOI: 10.1161/01.cir.98.21.2334. View

2.
Hernandez A, Fonarow G, Liang L, Al-Khatib S, Curtis L, LaBresh K . Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA. 2007; 298(13):1525-32. DOI: 10.1001/jama.298.13.1525. View

3.
Irvine J, Dorian P, Baker B, OBrien B, Roberts R, Gent M . Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J. 2002; 144(2):282-9. DOI: 10.1067/mhj.2002.124049. View

4.
Buxton A, Lee K, Fisher J, Josephson M, Prystowsky E, Hafley G . A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999; 341(25):1882-90. DOI: 10.1056/NEJM199912163412503. View

5.
Bardy G, Lee K, Mark D, Poole J, Packer D, Boineau R . Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005; 352(3):225-37. DOI: 10.1056/NEJMoa043399. View